Yes, it seems the shorts are desperately bringing back posts from May to try and make old news new again - and divert attention from the big potential of Ampion and Optima. All it takes is ONE drug to send this stock to a quick double or 3X. Even IF Zertane were dead (which it is NOT), AMPE will ROCKET on ANY new positive news.
So is Zertane not relevant any more? Seems to me that since AMPE continues to not live up to what it promised for zertane (i.e. when it said last year it would start 2 clinical trials, or when it said two months ago there would be a partnership soon) this continues to be relevant.
Ignore all the facts you like, selling shares to fools like you in the high 6s has worked out well.